Guillain-Barre syndrome after SARS-CoV-2 infection in an international prospective cohort study.

ABSTRACT: In the wake of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, an increasing number of patients with neurological disorders, including Guillain-Barré syndrome (GBS), have been reported following this infection. It remains unclear, however, if these cases are coincidental or not, as most publications were case reports or small regional retrospective cohort studies. The International GBS Outcome Study is an ongoing prospective observational cohort study enrolling patients with GBS within 2 weeks from onset of weakness. Data from patients included in this study, between 30 January 2020 and 30 May 2020, were used to investigate clinical and laboratory signs of a preceding or concurrent SARS-CoV-2 infection and to describe the associated clinical phenotype and disease

SUBMITTER: Luijten LWG 

PROVIDER: S-EPMC8677532 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature